HPLC shadowing: artifacts in peptide characterization monitored by RIA. 1984

A J Fischman, and A J Kastin, and M V Graf

High performance liquid chromatography (HPLC), a valuable tool for characterization of peptides, is frequently used in combination with sensitive radioimmunoassays (RIA). The shadow phenomenon, representing carry-over of the peptide from previous application of the standard, can appear to result in the presence of endogenous peptide in the test sample when none is actually there. With delta sleep-inducing peptide (DSIP), we found the shadowing to be as high as 10%, although it was only 1% with 125I-Tyr-DSIP. Thus, when HPLC-RIA systems are used for identification of peptides, caution must be used to avoid false positive results.

UI MeSH Term Description Entries
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003701 Delta Sleep-Inducing Peptide A nonapeptide that is found in neurons, peripheral organs, and plasma. This neuropeptide induces mainly delta sleep in mammals. In addition to sleep, the peptide has been observed to affect electrophysiological activity, neurotransmitter levels in the brain, circadian and locomotor patterns, hormonal levels, psychological performance, and the activity of neuropharmacological drugs including their withdrawal. DSIP,Delta Sleep Inducing Peptide,Delta-Sleep Peptide,Delta-Sleep-Inducing Peptide,Delta-Sleep-Inducing-Peptide,Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu,Delta Sleep Peptide,Peptide, Delta Sleep-Inducing,Peptide, Delta-Sleep,Peptide, Delta-Sleep-Inducing,Sleep-Inducing Peptide, Delta,Trp Ala Gly Gly Asp Ala Ser Gly Glu
D005189 False Positive Reactions Positive test results in subjects who do not possess the attribute for which the test is conducted. The labeling of healthy persons as diseased when screening in the detection of disease. (Last, A Dictionary of Epidemiology, 2d ed) False Positive Reaction,Positive Reaction, False,Positive Reactions, False,Reaction, False Positive,Reactions, False Positive

Related Publications

A J Fischman, and A J Kastin, and M V Graf
May 1985, European journal of radiology,
A J Fischman, and A J Kastin, and M V Graf
January 1990, Journal of biochemical and biophysical methods,
A J Fischman, and A J Kastin, and M V Graf
January 2017, Methods in molecular biology (Clifton, N.J.),
A J Fischman, and A J Kastin, and M V Graf
January 1979, Veterinary and human toxicology,
A J Fischman, and A J Kastin, and M V Graf
April 1987, American journal of clinical pathology,
A J Fischman, and A J Kastin, and M V Graf
August 2020, International ophthalmology,
A J Fischman, and A J Kastin, and M V Graf
April 1990, Research communications in chemical pathology and pharmacology,
A J Fischman, and A J Kastin, and M V Graf
April 1994, Prostaglandins,
A J Fischman, and A J Kastin, and M V Graf
June 1990, Transplantation proceedings,
A J Fischman, and A J Kastin, and M V Graf
August 2003, Journal of pharmaceutical and biomedical analysis,
Copied contents to your clipboard!